celdoxome pegylated liposomal
yes pharmaceutical development services gmbh - clorhidrato de doxorrubicina - breast neoplasms; ovarian neoplasms; multiple myeloma; sarcoma, kaposi - agentes antineoplásicos - celdoxome pegylated liposomal is indicated in adults:as monotherapy for patients with metastatic breast cancer, where there is an increased cardiac risk. or treatment of advanced ovarian cancer in women who have failed a first-line platinum-based chemotherapy regimen. in combination with bortezomib for the treatment of progressive multiple myeloma in patients who have received at least one prior therapy and who have already undergone or are unsuitable for bone marrow transplant. for treatment of aids-related kaposi’s sarcoma (ks) in patients with low cd4 counts (< 200 cd4 lymphocytes/mm3) and extensive mucocutaneous or visceral disease. celdoxome pegylated liposomal may be used as first-line systemic chemotherapy, or as second line chemotherapy in aids-ks patients with disease that has progressed with, or in patients intolerant to, prior combination systemic chemotherapy comprising at least two of the following agents: a vinca alkaloid, bleomycin and standard doxorubicin (or other anthracycline).
inegy 10/20 mg 28 comprimits
inegy 10/40 mg 28 comprimits
fentanilo matrix viatris 50 mcg/h parches transdermicos efg
viatris limited - fentanilo - parche transdÉrmico - 50 microgramos/h - fentanilo 50 microgramos/h - fentanilo
nisoplus 50 50 mg tableta
rucef s.a.c. - tableta - por ; prednisona 50.000000 mg; - prednisona
mifegyne 200 mg 3 comprimits
trelegy ellipta 92/55/22 mcg/dosis 1 inhalador 30 dosis
mibi institute of atomic energy 1 mg equipo de reactivos para preparacion radiofarmaceutica efg
narodowe centrum badan jadrowych - [tetrakis (2-metoxi-2-metilpropil-1-isocianuro) cobre (i)], tetrafluoroborato de - equipo de reactivos para preparaciÓn radiofarmacÉutica - 1 mg - [tetrakis (2-metoxi-2-metilpropil-1-isocianuro) cobre (i)], tetrafluoroborato de 1 mg - tecnecio (99mtc) sestamibi
mifegyne 200 mg
laboratoires macors, auxerre, francia. - mifepristona - comprimido - 200 mg
mifegyne® 200 mg
laboratoires macors - mifepristona - comprimido - 200 mg